4.6 Review

Neuroinflammation and the generation of neuropathic pain

Journal

BRITISH JOURNAL OF ANAESTHESIA
Volume 111, Issue 1, Pages 26-37

Publisher

ELSEVIER SCI LTD
DOI: 10.1093/bja/aet128

Keywords

immune response; pain; neuropathic

Categories

Funding

  1. Pfizer
  2. Astellas
  3. Acorda
  4. Wellcome Trust [095698/z/11/z]
  5. MRC/CASE
  6. Wellcome Trust [095698/Z/11/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Inflammation is the process by which an organism responds to tissue injury involving both immune cell recruitment and mediator release. Diverse causes of neuropathic pain are associated with excessive inflammation in both the peripheral and central nervous system which may contribute to the initiation and maintenance of persistent pain. Chemical mediators, such as cytokines, chemokines, and lipid mediators, released during an inflammatory response have the undesired effect of sensitizing and stimulating nociceptors, their central synaptic targets or both. These changes can promote long-term maladaptive plasticity resulting in persistent neuropathic pain. This review aims to provide an overview of inflammatory mechanisms at differing levels of the sensory neuroaxis with a focus on neuropathic pain. We will compare and contrast neuropathic pain states such as traumatic nerve injury which is associated with a vigorous inflammatory response and chemotherapy induced pain in which the inflammatory response is much more modest. Targeting excessive inflammation in neuropathic pain provides potential therapeutic opportunities and we will discuss some of the opportunities but also the clinical challenges in such an approach.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available